Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-227361
Filing Date
2024-09-27
Accepted
2024-09-27 08:01:05
Documents
5
Effectiveness Date
2024-09-27

Document Format Files

Seq Description Document Type Size
1 S-8 d896802ds8.htm S-8 39560
2 EX-5.1 d896802dex51.htm EX-5.1 8507
3 EX-23.2 d896802dex232.htm EX-23.2 1264
4 EX-FILING FEES d896802dexfilingfees.htm EX-FILING FEES 12975
5 GRAPHIC g896802g0925100609121.jpg GRAPHIC 2537
  Complete submission text file 0001193125-24-227361.txt   67042
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-282360 | Film No.: 241330600
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)